1647-Epi-Allele Silencing Prevents Haploinsufficiency in DGD

Paper Talk · Oct 5, 2026 · 24m

Researchers have developed a novel therapeutic strategy called Epi-Allele, which utilizes allele-specific epigenetic silencing to treat dominant genetic diseases. Unlike traditional gene-editing methods that risk causing harmful haploinsufficiency, this approach selectively deactivates a pathogenic allele while simultaneously triggering a compensatory increase in the expression of the healthy, non-targeted allele. This mechanism preserves the total gene output, effectively rebalancing the cell's genetic expression without reducing necessary protein levels. The study demonstrates the…